| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |